Genmab — Maj 2016
-
-
-
Kampen om Medivation fortsætter: May 24 (Reuters) - France's Sanofi SA SASY.PA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc MDVN.O as early as Wednesday, according to people familiar with the matter.
Sanofi has threatened to oust the board after Medivation rejected its unsolicited $9.3 billion acquisition offer late last month, taking advantage of a so-called 'written consent' rule that gives Medivation shareholders th -
shareholders the ability to act at any time to replace directors.
Medivation has declined to engage in sale talks with Sanofi unless the latter raises its $52.50 per share cash offer first, sources have said. The French drugmaker has said it is willing to raise its bid only after Medivation engages with it in negotiations. (Full Story)
Medivation shares ended trading on Tuesday in New York at $61.91. -
Medivation has signed non-disclosure agreements to share confidential information with other pharmaceutical companies interested in an acquisition, including Pfizer Inc PFE.N and Amgen Inc AMGN.O, sources told Reuters earlier this month. (Full Story)
-
Carnegie er bull: http://play.borsen.dk/social/57448490725ed7540a0d572c
-
Da det så er Chicago tid, så skal lægge 7 timer til.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind